Tectonic Therapeutic, Inc. (TECX)
20.80
+0.15
(+0.73%)
USD |
NASDAQ |
Oct 19, 14:43
Tectonic Therapeutic EPS Diluted (Quarterly) : -1.175 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.175 |
| March 31, 2026 | -1.345 |
| December 31, 2025 | -1.027 |
| September 30, 2025 | -1.017 |
| June 30, 2025 | -1.070 |
| March 31, 2025 | -0.927 |
| December 31, 2024 | -0.8364 |
| September 30, 2024 | -1.203 |
| June 30, 2024 | -4.340 |
| March 31, 2024 | -10.97 |
| December 31, 2023 | -5.590 |
| September 30, 2023 | -91.46 |
| June 30, 2023 | -102.10 |
| March 31, 2023 | -6.801 |
| December 31, 2022 | -6.860 |
| September 30, 2022 | -6.297 |
| June 30, 2022 | -7.704 |
| March 31, 2022 | -8.193 |
| December 31, 2021 | -7.760 |
| Date | Value |
|---|---|
| September 30, 2021 | -8.971 |
| June 30, 2021 | -0.7383 |
| March 31, 2021 | -7.756 |
| December 31, 2020 | -8.762 |
| September 30, 2020 | -12.11 |
| June 30, 2020 | -9.581 |
| March 31, 2020 | -9.258 |
| December 31, 2019 | -8.598 |
| September 30, 2019 | -6.791 |
| June 30, 2019 | -8.012 |
| March 31, 2019 | -8.590 |
| December 31, 2018 | -8.081 |
| September 30, 2018 | -5.857 |
| June 30, 2018 | -35.76 |
| March 31, 2018 | -5.256 |
| December 31, 2017 | -3.827 |
| September 30, 2017 | -3.229 |
| June 30, 2017 | -1.282 |
| March 31, 2017 | -1.065 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -22.28M |
| Total Expenses (Quarterly) | 22.28M |
| Enterprise Value | 174.54M |
| Earnings Yield | -21.94% |
| Normalized Earnings Yield | -21.94 |